Clinical Trials

48 enrolled

Ovarian Neoplasms

NCT05412225 2026-02-11

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase 1 Recruiting

60 enrolled

Breast Neoplasms

NCT06417190 2026-02-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

20 enrolled

Tumor-Agnostic

Neoplasms

NCT06739655 2026-02-04

PRADAIIBE

180 enrolled

Breast Neoplasms, Neoplasms

NCT07383818 2026-02-03

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

111 enrolled

Breast Neoplasms

NCT07385001 2026-02-03

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Phase 1/2 Recruiting

45 enrolled

Esophageal Squamous Cell Carcinoma

NCT04495088 2026-02-02

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

550 enrolled

Rectal Neoplasms

NCT07370337 2026-01-27

Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal

50 enrolled

Squamous Cell Carcinoma of External Auditory Canal

NCT06405321 2026-01-14

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

2,000 enrolled

Carcinoma, Hepatocellular

NCT07103395 2026-01-14

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

56 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06498154 2025-12-19

Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy

200 enrolled

Breast Neoplasms

NCT04908696 2025-12-04

Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)

1,000 enrolled

Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT03926338 2025-11-20

PICC

270 enrolled

Turcot syndrome, Colorectal Neoplasms

NCT04727307 2025-09-30

AB-LATE02

202 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT07081360 2025-08-29

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

262 enrolled

Pancreatic Neoplasms

NCT07084610 2025-08-22

Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06664411 2025-08-19

Pola-ZR2P in Previously Untreated DLBCL

80 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06611813 2025-08-12

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

Breast Neoplasms

NCT06874933 2025-08-12

Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)

35 enrolled

Breast Neoplasms

NCT06734702 2025-07-24

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

497 enrolled

Thoracic

Neoadjuvant Therapy

NCT04268121 2025-07-23

NEONEC

EndocrineGastrointestinal

78 enrolled

Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine

NCT07054086 2025-07-08

Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Esophageal Neoplasms

NCT07040098 2025-06-26

STELLARIII

228 enrolled

Locally Advanced Rectal Cancer (LARC)

NCT06235203 2025-06-03

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

154 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06978322 2025-05-18

Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Surgery

NCT05365893 2025-04-16

PHL Treatment in Pancreatic Cancer

20 enrolled

Pancreatic Ductal Adenocarcinoma

NCT06712420 2025-04-16

NEOGB

114 enrolled

Gallbladder Neoplasms

NCT06045975 2025-04-02

DUMELEP

Carcinoma, Hepatocellular

NCT05179447 2025-04-01

PROBEAT

590 enrolled

Endometrial Neoplasms

NCT06878222 2025-04-01

Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC

35 enrolled

Uterine Cervical Neoplasms

NCT05296746 2025-03-18

RIBOLARIS

1,100 enrolled

Breast Neoplasms

NCT05992870 2025-03-17

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

40 enrolled

Breast Neoplasms

NCT04460352 2025-03-06

NEEDS

1,020 enrolled

Esophageal Squamous Cell Carcinoma

NCT04016675 2025-02-25

Neoadjuvant Radiotherapy for Malignant Lacrimal Sac Tumors

94 enrolled

Malignant Tumor of Lacrimal Drainage Structure

NCT06832904 2025-02-18

Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)

33 enrolled

HER2-positive Breast Cancer

NCT06793553 2025-01-30

INDUCE

106 enrolled

Breast Neoplasms

NCT06792149 2025-01-24

Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting

60 enrolled

Stomach Neoplasms

NCT06642428 2025-01-17

Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer

140 enrolled

Breast Neoplasms

NCT06385288 2024-12-06

Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas

Sarcoma

NCT05496491 2024-10-08

Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

84 enrolled

Neoplasms, Rectal Neoplasms

NCT02089100 2024-08-15

STEREO-SEIN

280 enrolled

Breast Neoplasms

NCT05216900 2024-06-21

BRENAR

20 enrolled

Breast Neoplasms

NCT06369480 2024-04-17

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

2,000 enrolled

Cholangiocarcinoma

NCT06313073 2024-03-15

Neoadjuvant Radiotherapy for Breast Cancer

60 enrolled

Breast Neoplasms

NCT04378647 2024-02-26

BRESELIBET

150 enrolled

Lymphoid

Hodgkin Disease

NCT05173272 2023-12-27

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

286 enrolled

Uterine Cervical Neoplasms

NCT04902937 2023-11-28

CETC

200 enrolled

Neoplastic Cells, Circulating

NCT06080620 2023-10-12

The Choice of Treatment Methods and Efficacy of LABC

50 enrolled

Locally Advanced Breast Cancer

NCT05984485 2023-08-09

TaLaR-02

766 enrolled